Cargando…

Distinction between induction and maintenance dosing in continuous renal replacement therapy

Detalles Bibliográficos
Autor principal:	MacLaren, Graeme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219394/ https://www.ncbi.nlm.nih.gov/pubmed/21586103 http://dx.doi.org/10.1186/cc10137

Ejemplares similares

Optimising the timing of renal replacement therapy in acute kidney injury
por: Cove, Matthew E., et al.
Publicado: (2021)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

Concurrent Use of Renal Replacement Therapy during Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-Analysis
por: Mitra, Saikat, et al.
Publicado: (2021)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy
por: Kiser, Tyree H, et al.
Publicado: (2015)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
por: Honore, Patrick M., et al.
Publicado: (2020)

Clearance of micronutrients during continuous renal replacement therapy
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

The furosemide stress test to predict renal function after continuous renal replacement therapy
por: van der Voort, Peter HJ, et al.
Publicado: (2014)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
por: Honore, Patrick M, et al.
Publicado: (2015)

Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
por: Dickie, Helen, et al.
Publicado: (2015)

Endocan is a reliable biomarker during continuous renal replacement therapy
por: Hureau, Maxence, et al.
Publicado: (2019)

Variation of High-Sensitivity Troponin T Results in Patients Undergoing Continuous Renal Replacement Therapy
por: Srinivasan Sridhar, Vikas, et al.
Publicado: (2019)

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
por: Jacobs, Rita, et al.
Publicado: (2015)

Dosing patterns for continuous renal replacement therapy in the United States
por: Venkataraman, R, et al.
Publicado: (2001)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Lacosamide dosing in patients receiving continuous renal replacement therapy
por: Chaijamorn, Weerachai, et al.
Publicado: (2023)

Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies
por: Kempke, Anna P., et al.
Publicado: (2016)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

Electronic health records accurately predict renal replacement therapy in acute kidney injury
por: Low, Sanmay, et al.
Publicado: (2019)

Early mobilization on continuous renal replacement therapy is safe and may improve filter life
por: Jacobs, Frederic M
Publicado: (2015)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
por: Aguilar, Gerardo, et al.
Publicado: (2020)

Preparing for COVID-19: early experience from an intensive care unit in Singapore
por: Liew, Mei Fong, et al.
Publicado: (2020)

Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
por: Li, Lu, et al.
Publicado: (2020)

Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
por: Honore, Patrick M, et al.
Publicado: (2015)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
por: Honore, Patrick M., et al.
Publicado: (2015)

Autopsy examination after extracorporeal membrane oxygenation: ‘Mortuis vivos docent’
por: Ramanathan, Kollengode, et al.
Publicado: (2020)

When to initiate ECMO with low likelihood of success
por: MacLaren, Graeme
Publicado: (2018)

Renal replacement therapy in severe COVID-19 patients: Intermittent or continuous, the ongoing debate
por: Gaudray, Eliott, et al.
Publicado: (2021)

Commentary: Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
por: Matusik, Elodie
Publicado: (2020)

Continuous Renal Replacement Therapy Dosing in the Severely Underweight: A Case Report
por: Griffin, Benjamin R., et al.
Publicado: (2019)

Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0aeaulpf0li11ddrflomaj6i2p